KACY KIRK: Open Payments
NPI 1063950160 · TULLAHOMA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 32 payments from 9 companies in 2025. Trend: 2023 $437 · 2024 $973 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $207 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Tris Pharma Inc | 4 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| ABBVIE INC. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Alkermes, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: AUSTEDO XR, INGREZZA, Dyanavel XR, COBENFY, UZEDY, VRAYLAR, CAPLYTA, ARISTADA.
Industry payments across TN — which companies pay providers there.
